BANK OF AMERICA CORP /DE/
BankPosition in AGIO — Agios Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in AGIO
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$17,182,254
+$2,501,396 QoQ
Shares Held
507,900
-5.8% QoQ
Ownership
0.854%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Jun 30, 2023CallValue
$849,600
CallShares
30,000
PutValue
$849,600
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. AGIO ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in AGIO
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,182,254 | 507,900 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $14,680,858 | 539,341 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $37,261,443 | 1,120,308 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $33,272,844 | 1,135,592 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,305,077 | 404,902 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,798,520 | 333,075 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,090,750 | 326,780 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,161,871 | 381,733 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,586,593 | 205,954 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,796,175 | 274,593 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,165,127 | 253,006 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $849,600 | 30,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $849,600 | 30,000 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $682,209 | 29,700 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $682,209 | 29,700 | Put | Defined | 2023-05-12 | |
| 2023-03-31 | $9,726,230 | 423,432 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,398,263 | 263,471 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,014,464 | 283,397 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,595,106 | 162,161 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,776,355 | 267,137 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,275,255 | 282,180 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,297,671 | 136,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,154,650 | 166,116 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $7,759,630 | 150,264 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,914,498 | 136,499 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,656,805 | 161,623 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,155,237 | 171,190 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,919,882 | 251,406 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||